Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Edgewise Therapeutics, Inc. (EWTX), most recent 12 months reported: net loss $197.22M, free cash flow -$158.83M. Latest balance sheet on file: liquid cash $460.71M. From SEC filings. More on Edgewise Therapeutics, Inc.: Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: EUPRAXIA PHARMACEUTICALS INC. · EQUILLIUM, INC. · Erasca, Inc. · Ernexa Therapeutics Inc. · FibroBiologics, Inc. · Filana Therapeutics, Inc. · Faeth Therapeutics, Inc. · FULCRUM THERAPEUTICS, INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.